Exhalation of 131I after radioiodine therapy: Measurements in exhaled air

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 12, 2011, Pages 2165-2172

  Schomäcker, Klaus ^a   Sudbrock, Ferdinand ^a   Fischer, Thomas ^a   Dietlein, Markus ^a   Kobe, Carsten ^a   Gaidouk, Mark ^a   Schicha, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Exhalation; Radioiodine therapy; Thyroid

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG HALF LIFE; EXHALATION; EXPIRED AIR; FEMALE; GRAVES DISEASE; HUMAN; MALE; RADIATION EXPOSURE; RADIOACTIVITY; THYROID CANCER; THYROID DISEASE; THYROIDECTOMY; TOXIC GOITER; AIR; BREATH ANALYSIS; COMPARATIVE STUDY; EXPOSURE; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; AIR; BREATH TESTS; FEMALE; HUMANS; INHALATION EXPOSURE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; THYROID DISEASES;

EID: 84856212598     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1888-8     Document Type: Article

References (28)

1. Salvatori M, Luster M. Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2010;37:821-8.
2. Verburg FA, Dietlein M, Lassmann M, Luster M, Reiners C. Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2009;36:343-6.
3. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, et al.; European Association of Nuclear Medicine (EANM). Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008;35:1941-59.
4. Stahl AR, Freudenberg L, Bockisch A, Jentzen W. A novel view on dosimetry-related radionuclide therapy: presentation of a calculatory model and its implementation for radioiodine therapy of metastasized differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2009;36:1147-55.
5. Kobe C, Weber I, Eschner W, Sudbrock F, Schmidt M, Dietlein M, Schicha H. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication? Nucl Med 2008;47:153-6.
6. Kobe C, Eschner W, Wild M, Rahlff I, Sudbrock F, Schmidt M, et al. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I? Nucl Med Commun. 2010;31:201-5.
7. Mulazimoglu M, Edis N, Tamam MO, Uyanik E, Ozpacaci T. The evaluation of the external dose measurement of the patients treated with radioiodine therapy. Radiat Prot Dosimetry. 2010;141:233-8.
8. Flux GD, Haq M, Chittenden SJ, Buckley S, Hindorf C, Newbold K, et al. A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2010;37:270-5.
9. Barrington SF, Kettle AG, O'Doherty MJ, Wells CP, Somer EJ, Coakley AJ. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med. 1996;23:123-30. (Pubitemid 26056988)
10. Erratum in: Eur J Nucl Med 1997;24:1545.
11. Barrington SF, O'Doherty MJ, Kettle AG, Mountford PJ. Dose rate measurements combined with social behavior models enables estimation of potential radiation hazards to families of patients treated with radioiodine. Health Phys. 2000;78:100-1. (Pubitemid 30004788)
12. Barrington SF, Anderson P, Kettle AG, Gadd R, Thomson WH, Batchelor PJ. Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism. Eur J Nucl Med Mol Imaging. 2008;35:2097-104.
13. Barrington SF, O'Doherty MJ, Kettle AG, Thomson WH, Mountford PJ, Burrell DN, et al. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med. 1999;26:686-92. (Pubitemid 29338655)
14. Pant GS, Sharma SK, Bal CS, Kumar R, Rath GK. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I. Radiat Prot Dosimetry. 2006;118:22-7. (Pubitemid 43786724)
15. Lassmann M, Hänscheid H, Schelper LF, Körber C, Reiners C. Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases. Nucl Med. 1998;37:120-3. (Pubitemid 28223789)
16. Nishizawa K, Ohara K, Ohshima M, Maekoshi H, Orito T, Watanabe T. Monitoring of I excretions and used materials of patients treated with 131I. Health Phys. 1980;38:467-81. (Pubitemid 10109796)
17. Reiners C, Lassmann M. Radioiodine (131I) treatment of hyperthyroidism: radiation protection and quality assurance. Eur J Nucl Med. 1999;26:683-5. (Pubitemid 29338654)
18. Krześniak JW, Chomicki OA, Czerminska M, Gorowski T. Airborne radioiodine contamination caused by I-131 treatment. Nucl Med. 1979;18:246-51. (Pubitemid 10202781)
19. Krześniak JW, Fill H, Oberladstätter M. Radioactivity levels of the air inhaled by personnel of a radioiodine therapy unit. Nucl Med. 1987;26:143-6. (Pubitemid 17133373)
20. Heinemann K, Vogt KJ, Friedrich W, Feinendegen LE. Monitoring of radioiodine in nuclear medical therapy. Strahlentherapie. 1983;159:490-4. (Pubitemid 13001411)
21. Schomäcker K, Fischer T, Eschner W, Gaidouk MI, Schicha H. Exhalation of I-131 after radioiodine therapy (RIT): time dependence and chemical form. Nucl Med. 2001;40:15-22. (Pubitemid 32163552)
22. Deuber H, Wilhelm JG. Occurrence of penetrating iodine species in the exhaust air of PWR power plants. In: First MW, editor. Proceedings of the 16th DOE Nuclear Air Cleaning Conference. CONF-801038, vol 2; 1981. p. 1354-86. (Pubitemid 14635836)
23. Wilhelm JG, Deuber H, Wilhelm JG, Deuber H. The removal of short-lived iodine isotopes. In: Goossens W, editor. Treatment of gaseous effluents at nuclear facilities. Chur: Harwood; 1991. p. 67-96.
24. Wilhelm JG. Development and application of filters for air cleaning in nuclear power plants. Nucl Eng Des. 1987;103:139-47.
25. Wellner U, Eschner W, Hillger HW, Schicha H. Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes. Nucl Med. 1998;37:113-9. (Pubitemid 28223788)
26. Sudbrock F, Schomäcker K, Fischer T, Zimmermanns B, Dietlein M, Kobe C, et al. Exhalation of I-131 after radioiodine therapy: measurements in exhaled air and dosimetric considerations. Nucl Med. 2011;2:A71.
27. Sudbrock F, Boldt F, Kobe C, Hammes J, Eschner W, Schicha H. Radiation exposure of patients after application of radiopharmaceuticals. Part 2: therapeutic procedures. Nucl Med. 2009;48(1):17-25.
28. Gründel M, Kopka B, Schulz R. 131I exhalation by patients undergoing therapy of thyroid diseases. Radiat Prot Dosimetry. 2008;129:435-8.